SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parenteral Drugs (India) informs about post-facto intimation of CoC

20 Jan 2024 Evaluate

Parenteral Drugs (India) has informed that that the sixth meeting of Committee of Creditors (CoC), pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR) and in accordance with the requirements of sub-clause 16(g) of Clause A of Part A of Schedule III of Listing Regulations, of the Company was held on Friday, 19th January, 2024 at 12:00 Noon.

The above information is a part of company’s filings submitted to BSE.

Parenteral Drugs Share Price

3.39 0.00 (0.00%)
21-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.75
Dr. Reddys Lab 1219.65
Cipla 1231.15
Zydus Lifesciences 928.40
Lupin 2320.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×